Advertisement
News
Advertisement

Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010

Mon, 11/01/2010 - 6:33am
Bio-Medicine.Org

MOUNTAIN VIEW, Calif., Nov. 1, 2010 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it will report results for its fiscal quarter ended September 30, 2010, on Tuesday, November 9, 2010 following the close of the U.S. financial markets.  As the Company recently held an investor conference call on October 11th, there will not be a conference call held in conjunction with the release of the Company's third quarter results.  The Company will provide a regulatory update regarding its AZ-004 New Drug Application (NDA) after conducting a follow-on meeting with the U.S. Food and Drug Administration (FDA).

About Alexza Pharmaceuticals, Inc.

Alexza Pharmaceuticals is a pharmaceutical company focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions. Alexza's technology, the Staccato® system, vaporizes unformulated drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. (Click here to see an animation of how the Staccato system works.)

AZ-004 (Staccato loxapine) is Alexza's lead program, which is being developed for the rapid treatment of agitation in schizophrenic or bipolar disorder patients. Alexza has completed and announced positive results from both of its AZ-004 Phase 3 clinical trials and submitted a New Drug Application in December 2009.  In October 2010, the Company received a Complete Response Letter (CRL) from th

'/>"/>

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading